Rally Foundation Grants $500,000 to Blood Cancer United
The grant funds Dare to Dream REALworld: AML, a real-world evidence initiative for rare pediatric acute myeloid leukemia.
Updated on Nov. 10, 2026 in Cancer

The Rally Foundation for Childhood Cancer Research, founded in East Cobb in 2005, has awarded $500,000 to Blood Cancer United, the largest grant it has given to a single organization. The funding launches Dare to Dream REALworld: AML, which the two groups co-founded to study pediatric acute myeloid leukemia.
Why it matters
Pediatric acute myeloid leukemia is rare, and small patient populations make traditional clinical trials difficult to run. The initiative aims to build a data set that researchers can use to design more efficient trials.
The Rally Foundation has awarded $47.5 million in grants since 2005, and Rally-funded research has helped advance eight FDA-approved drugs and more than 20 active pediatric cancer trials. How many children will ultimately contribute records to the new initiative has not been disclosed.
The players
Rally Foundation for Childhood Cancer Research
A nonprofit founded in East Cobb in 2005 that funds research into childhood cancers and has awarded $47.5 million in grants since its founding.
Blood Cancer United
A patient-focused nonprofit that provides education and support to people affected by blood cancers and is a co-founder of REALworld: AML.
Tempus
A technology company providing data and software tools for the initiative, including its Olivia personal health concierge app.
The details
Families can take part by sharing electronic health records from children living with or in remission from pediatric AML. Participants receive educational information from Blood Cancer United tailored to their child's diagnosis, treatment and support needs. Tempus is providing technology for the initiative, including its Olivia personal health concierge app.
Timeline
2005: Rally Foundation for Childhood Cancer Research is founded in East Cobb.
November 10, 2026: Rally Foundation announces the $500,000 grant to Blood Cancer United.
Health Landscape
The REALworld initiative extends the pediatric trial-design problem that the PedAL clinical trial, which screened 660 children across 100 medical centers worldwide, encountered with small patient populations. Building a shared real-world data set is an attempt to make future trials for rare pediatric leukemias more feasible.
Families of children with pediatric AML who are living with or in remission from the disease can choose to share electronic health records with the initiative. Participation involves receiving educational material tailored to the child's diagnosis, treatment and support needs.
The takeaway
Pooling real-world patient records is one practical route to making trials for rare pediatric cancers feasible when enrollment is small. Families who want to contribute can start by reading the initiative's information page.
Further reading
Explore more Cancer coverage for context on how research groups are working to speed up treatment for rare childhood leukemias.
More information
Learn more on the Dare to Dream REALworld: AML information page from Blood Cancer United.
Source note: This article includes information reported by MDJOnline.










